phenserine has been researched along with galantamine in 3 studies
Studies (phenserine) | Trials (phenserine) | Recent Studies (post-2010) (phenserine) | Studies (galantamine) | Trials (galantamine) | Recent Studies (post-2010) (galantamine) |
---|---|---|---|---|---|
88 | 6 | 39 | 1,874 | 209 | 703 |
Protein | Taxonomy | phenserine (IC50) | galantamine (IC50) |
---|---|---|---|
Chain A, ACETYLCHOLINESTERASE | Tetronarce californica (Pacific electric ray) | 0.652 | |
Chain A, Acetylcholinesterase | Tetronarce californica (Pacific electric ray) | 0.36 | |
Acetylcholinesterase | Electrophorus electricus (electric eel) | 2.0401 | |
Acetylcholinesterase | Tetronarce californica (Pacific electric ray) | 0.488 | |
Cholinesterase | Homo sapiens (human) | 5.4792 | |
Vascular endothelial growth factor receptor 1 | Homo sapiens (human) | 0.59 | |
Acetylcholinesterase | Mus musculus (house mouse) | 2.29 | |
Acetylcholinesterase | Homo sapiens (human) | 1.8484 | |
Acetylcholinesterase | Bos taurus (cattle) | 4.53 | |
Delta-type opioid receptor | Mus musculus (house mouse) | 8.3973 | |
Vascular endothelial growth factor receptor 3 | Homo sapiens (human) | 0.59 | |
Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 0.59 | |
Acetylcholinesterase | Rattus norvegicus (Norway rat) | 0.8006 | |
Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 3.2 | |
Cholinesterase | Equus caballus (horse) | 7.2215 | |
Carboxylic ester hydrolase | Equus caballus (horse) | 8.4178 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brossi, A; Greig, NH; Holloway, HW; Whittaker, NF; Yu, QS; Zhu, X | 1 |
Alley, GM; Brossi, A; Deschamps, JR; Greig, NH; Holloway, HW; Kulkarni, SS; Lahiri, DK; Luo, W; Parrish, D; Yu, QS; Zhan, M | 1 |
Castro, A; Martinez, A | 1 |
1 review(s) available for phenserine and galantamine
Article | Year |
---|---|
Novel cholinesterase inhibitors as future effective drugs for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Butyrylcholinesterase; Carbamates; Cholinesterase Inhibitors; Clinical Trials as Topic; Drug Delivery Systems; Drug Evaluation, Preclinical; Galantamine; Humans; Physostigmine; Protein Conformation | 2006 |
2 other study(ies) available for phenserine and galantamine
Article | Year |
---|---|
Anticholinesterase activity of compounds related to geneserine tautomers. N-Oxides and 1,2-oxazines.
Topics: Acetylcholinesterase; Alkaloids; Butyrylcholinesterase; Cholinesterase Inhibitors; Cyclic N-Oxides; Humans; Isomerism; Oxazines; Structure-Activity Relationship | 2002 |
Novel anticholinesterases based on the molecular skeletons of furobenzofuran and methanobenzodioxepine.
Topics: Acetylcholinesterase; Amyloid beta-Protein Precursor; Benzofurans; Butyrylcholinesterase; Carbamates; Cell Line; Cell Survival; Cholinesterase Inhibitors; Crystallography, X-Ray; Humans; Models, Molecular; Molecular Structure; Neurons; Oxepins; Structure-Activity Relationship | 2005 |